Farxiga CKD Trial Stopped Early For Efficacy, Giving The SGLT2 Inhibitor An Edge

 
• By Jessica Merrill
Business success concept with target as motivation (3D Rendering)
AstraZeneca's Farxiga was successful in chronic kidney disease • Source: Shutterstock

More from Genitourinary

More from Therapeutic Category